Appendicectomy as a potential therapy for refractory ulcerative proctitis

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 2, 2011, Pages 257-258

  Bageacu, S ^a   Coatmeur, O ^b   Lemaitre, J P ^b   Lointier, P ^c   Del Tedesco, E ^a   Phelip, J M ^a   Roblin, X ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b Chataigneraie Clinic   (France)

^c La Plaine Clinic   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE;

ACUTE APPENDICITIS; APPENDECTOMY; DISEASE ACTIVITY; FOLLOW UP; FUSOBACTERIUM NECROPHORUM; FUSOBACTERIUM NUCLEATUM; HUMAN; INTESTINE ENDOSCOPY; LETTER; MUCOSA INFLAMMATION; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROCTITIS; REMISSION; TREATMENT OUTCOME; ULCERATIVE COLITIS; ULCERATIVE PROCTITIS;

ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE;

EID: 79959471981     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04705.x     Document Type: Letter

References (6)

1. Bouguen G, Roblin X, Bourreille A, et al. Infliximab for refractory ulcerative proctitis. Aliment Pharmacol Ther 2010; 31: 1178-85.
2. Andersson RE, Olaison G, Tysk C, Ekbom A,. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001; 344: 808-14. (Pubitemid 32222158)
3. Frisch M, Pedersen BV, Andersson RE,. Appendicitis, mesenteric lymphadenitis, and subsequent risk of ulcerative colitis: cohort studies in Sweden and Denmark. BMJ 2009; 338: b716.
4. Groux H, O'Garra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737-42. (Pubitemid 27458961)
5. Bolin TD, Wong S, Crouch R, Engelman JL, Riordan SM,. Appendicectomy as a therapy for ulcerative proctitis. Am J Gastroenterol 2009; 104: 2476-82.
6. Swidsinski A, Dörffel Y, Loening-Baucke V, et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 2011; 60: 34-40.